1. Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma. Issue 13 (25th September 2017) Authors: Noble, F; Lloyd, M A; Turkington, R; Griffiths, E; O'Donovan, M; O'Neill, J R; Mercer, S; Parsons, S L; Fitzgerald, R C; Underwood, T J; Noorani, A; Fels Elliott, R; Abdullahi, Z; de la Rue, R; Bornschein, J; MacRae, S; Nutzinger, B; Grehan, N; Contino, G; Crawte, J Journal: British journal of surgery Issue: Volume 104:Issue 13(2017) Page Start: 1816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O086 Genomic analysis of response to neoadjuvant chemotherapy in oesophageal adenocarcinoma. (22nd July 2022) Authors: Breininger, SP; Izadi, F; Sharpe, B; Secrier, M; Gibson, J; Walker, R; Rahman, S; Devonshire, G; Lloyd, M; Walters, Z; Fitzgerald, R; Rose-Zerilli, M; Underwood, T Journal: British journal of surgery Issue: Volume 109(2022)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 474 GENOMIC ANALYSIS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA. (14th September 2020) Authors: Izadi, F; Devonshire, G; Walker, R; Lloyd, M; Gibson, J; Secrier, M; Fitzgerald, R; Rose-Zerilli, M; Underwood, T Journal: Diseases of the esophagus Issue: Volume 33(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗